The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations (ImmunoTarget).
 
Julien Mazieres
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly/ImClone; MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Roche
 
Alexander E. Drilon
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Genentech/Roche; Ignyta; Loxo; Pfizer; Takeda; TP Therapeutics
 
Laurent Mhanna
No Relationships to Disclose
 
Julie Milia
No Relationships to Disclose
 
Amellie Lusque
No Relationships to Disclose
 
Alexis B. Cortot
Honoraria - Bristol-Myers Squibb; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; Pfizer; Roche
Research Funding - Merck Serono (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Laura Mezquita
No Relationships to Disclose
 
Alesha Thai
No Relationships to Disclose
 
Sebastien Couraud
No Relationships to Disclose
 
Remi Veillon
No Relationships to Disclose
 
Celine Mascaux
No Relationships to Disclose
 
Robert Schouten
No Relationships to Disclose
 
Joel W. Neal
Consulting or Advisory Role - ARIAD/Takeda; AstraZeneca; Boehringer Ingelheim; Lilly
Research Funding - ARIAD/Takeda; ArQule; Boehringer Ingelheim; Exelixis; Genentech/Roche; Merck; Nektar; Novartis
 
Terry L. Ng
Honoraria - ARIAD; ARIAD/Takeda
Consulting or Advisory Role - Boehringer Ingelheim
 
Martin Frueh
No Relationships to Disclose
 
Nir Peled
Consulting or Advisory Role - Advisor & Honorarium for AZ, BI, BMS, Lilly , MSD, Novartis, pfizer, Roche
Speakers' Bureau - Advisor & Honorarium for AZ, BI, BMS, Lilly , MSD, Novartis, pfizer, Roche
 
Valerie Gounant
No Relationships to Disclose
 
Sanjay Popat
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Guardant Health; Lilly; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Novartis; Pfizer; Roche
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Epizyme (Inst); Lilly (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme
 
Viola Weijia Zhu
Stock and Other Ownership Interests - TP Therapeutics (I)
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; Bayer; Biocept; TP Therapeutics
Speakers' Bureau - AstraZeneca; Roche/Genentech; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Roche Molecular Diagnostics; Roche/Genentech; Takeda; TP Therapeutics
 
Oliver Gautschi
No Relationships to Disclose